Letter: optimising response to ustekinumab therapy for patients with Crohn's disease-author's reply. Kopylov U. Aliment Pharmacol Ther 2020;52:907.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kopylov U. Letter: optimising response to ustekinumab therapy for patients with Crohn's disease-author's reply. Aliment Pharmacol Ther 2020;52:907.
PMID: 32852835